(Hypertension. 1999;34:931-936.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physiology and Biophysics and Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson.
| Abstract |
|---|
|
|
|---|
Key Words: hormones muscle, smooth, vascular constriction gender calcium
| Introduction |
|---|
|
|
|---|
The beneficial vascular effects of estrogen have been ascribed to a variety of factors, including endothelium-dependent vascular relaxation5 6 and endothelium-independent vascular relaxation, that involve direct action on vascular smooth muscle.2 3 7 8 Vascular smooth muscle contraction is triggered by increases in intracellular [Ca2+] due to Ca2+ release from the intracellular stores and Ca2+ entry from the extracellular space.9 We and others have reported that estrogen causes rapid relaxation of isolated segments of vascular smooth muscle7 8 10 and have suggested additional mechanisms independent of the classic genomic pathway of steroid action11 possibly mediated by an effect on Ca2+ mobilization and/or fluxes.
The suggested vascular protective effects of estrogen in females1 2 as opposed to their proposed absence in males12 imply gender-specific differences in vascular smooth muscle contractility. Additionally, the suggested vascular protective effects of estrogen in females with intact gonads as opposed to their proposed absence in females with reduced gonadal functions1 2 3 4 imply that vascular smooth muscle contractility may be modified by the presence or absence of functional female gonads. However, little is known about the effect of gender and the status of the gonads on the Ca2+ mobilization mechanisms of vascular smooth muscle contraction. In addition, since hypertension is often associated with changes in vascular reactivity,13 14 15 16 it is predicted that the gender-dependent changes in vascular reactivity may be altered in cases of hypertension. However, whether the effects of gender and the status of the gonads on vascular reactivity and the Ca2+ mobilization mechanisms of vasoconstriction are modified in hypertension is unclear.
The purpose of this study was as follows: (1) to determine whether vascular smooth muscle contractility is modified by gender and by the presence or absence of gender-specific gonads; (2) to determine whether the gender-specific changes in vascular reactivity reflect changes in the Ca2+ mobilization mechanisms of vascular smooth muscle contraction, ie, Ca2+ release from the intracellular stores and Ca2+ entry from the extracellular space; and (3) to determine whether the gender-specific changes in vascular contractility and Ca2+ mobilization mechanisms are modified in animal models of hypertension.
| Methods |
|---|
|
|
|---|
Blood Samples
On the day of the experiment, the rats were anesthetized
by inhalation of isoflurane. Blood was collected for measurement of
plasma 17ß-estradiol by radioimmunoassay with the use of a
17ß-estradiol kit (ICN Biomedicals). In WKY, plasma 17ß-estradiol
was 16±2 pmol/L (n=12) in intact males, 77±8 pmol/L (n=12) in intact
females, 18±3 pmol/L (n=12) in castrated males, 17±2 pmol/L (n=12) in
OVX females, and 83±9 pmol/L (n=8) in OVX females with 17ß-estradiol
implants. The plasma 17ß-estradiol in SHR was not significantly
different from that in WKY in each group of rats.
Isometric Tension
The thoracic aorta was excised, placed in oxygenated
Krebs' solution, and cleaned of connective tissue. The aorta was cut
transversely into 3-mm-wide rings. The endothelium was
removed by rubbing the vessel interior with forceps. Aortic rings were
cut open into strips. One end of the strip was attached to a glass hook
with a thread loop, and the other end was connected to a Grass force
transducer (FT03, Astro-Med). Aortic strips were stretched to maximum
length (1.5 initial unloaded length) and allowed to equilibrate
for 1 hour in a water-jacketed, temperature-controlled tissue bath
filled with 50 mL Krebs' solution continuously bubbled with 95%
O2/5% CO2 at 37°C. The
changes in isometric tension were recorded on a Grass polygraph
(model 7D, Astro-Med). Removal of the endothelium was
routinely verified by the absence of acetylcholine
(10-6 mol/L)induced vasorelaxation in aortic
strips precontracted with phenylephrine
(3x10-7 mol/L).
Three different agonists were used. The
-adrenergic agonist
phenylephrine was used to stimulate both
Ca2+ release from the intracellular
Ca2+ stores and Ca2+ entry
from the extracellular space.17 Caffeine was used to
activate Ca2+-induced
Ca2+ release in Ca2+-free
solution.18 Membrane depolarization by high KCl solution
was used to activate Ca2+ entry from the
extracellular space.9 17
Three protocols were followed in the present study. In the first protocol, the tissues were incubated in normal Krebs' solution (2.5 mmol/L Ca2+), and a maximal control contraction to phenylephrine (10-5 mol/L) was elicited. In some strips, when maximal phenylephrine contraction or contraction to the ED50 of phenylephrine (3x10-7 mol/L) reached a plateau, 17ß-estradiol was added at increasing concentrations, and the changes in tension were observed. In the second protocol, the bathing solution was changed to 96 mmol/L KCl solution to elicit a maximal contraction. In the third protocol, the tissues were incubated in normal Krebs' solution (2.5 mmol/L Ca2+) for 1 hour, transferred to Ca2+-free (2 mmol/L EGTA) Krebs' solution for 10 minutes, then stimulated with phenylephrine (10-5 mol/L) or caffeine (25 mmol/L) for 2 minutes or until the transient contraction returned to baseline.
45Ca2+ Influx
Aortic strips were incubated in normal Krebs' solution for 1
hour, then stimulated with phenylephrine
(10-5 mol/L) or 96 mmol/L KCl for 15
minutes. In some experiments, the tissues were pretreated with
17ß-estradiol (10-6 mol/L) for 30 minutes
before stimulation with phenylephrine. The tissues were
transferred to the respective radioactive
45Ca2+-labeled (ICN
Radiochemical) solution (specific activity, 2 µCi/mL) for 90 seconds,
then transferred to ice-cold Ca2+-free (2
mmol/L EGTA) Krebs' solution for 45 minutes to quench extracellular
45Ca2+
label.17 The tissue samples were weighed and placed in 2
mL hypotonic (5 mmol/L) EDTA for 24 hours at 4°C to disrupt the
cell membranes and release the intracellular content of
45Ca2+. The next day, 4 mL
of Ecolite scintillation cocktail was added, and the samples were
counted in a scintillation counter (Beckman LS 6500).
Solutions, Drugs, and Chemicals
Normal Krebs' solution contained the following (in
mmol/L): NaCl 120, KCl 5.9, NaHCO3 25,
NaH2PO4 1.2, dextrose 11.5,
MgCl2 1.2, CaCl2 2.5, at pH
7.4. For Ca2+-free Krebs' solution,
CaCl2 was omitted and replaced with 2 mmol/L
EGTA. The high-KCl depolarizing solution was prepared as Krebs' but
with equimolar substitution of NaCl with KCl. Stock solution of
phenylephrine (L-phenylephrine HCl;
Sigma) was prepared as 10-1 mol/L in distilled
water. Caffeine (Sigma) was prepared as 25 mmol/L in
Ca2+-free Krebs'. All other chemicals were of
reagent grade or better.
Statistical Analysis
The developed force was normalized for the cross-sectional area
of each individual strip and expressed as active stress
(N/m2) according to the equation
Stress=Force/Cross-Sectional Area, where cross-sectional area=wet
weight/(tissue densityxlength of the strip) and tissue density=1.055
g/cm3. Data were analyzed and expressed
as mean±SEM. Data were compared by ANOVA with 3 classification
criteria (strain, gender, and treatment [gonadectomized versus
intact]). Scheffé's F test was used for comparison of multiple
means. Student's t test for unpaired data was used for
comparison of 2 means. Differences were considered statistically
significant at P<0.05.
| Results |
|---|
|
|
|---|
15 minutes, and therefore the
phenylephrine response was compared at this time in all
groups of rats. Phenylephrine increased active stress to
15.92±0.65x103 N/m2 (n=8)
in intact male WKY (Figure 1A). The
phenylephrine-induced stress was significantly reduced
by 20% in intact female WKY. The phenylephrine-induced
stress was not significantly different between intact and castrated
males but was significantly greater in OVX females than in intact
females. There was no significant difference in the
phenylephrine-induced stress between OVX females and
castrated males. In OVX female WKY with 17ß-estradiol implants, the
phenylephrine-induced stress was not significantly
different from that in intact female WKY. In SHR, the
phenylephrine-induced active stress was significantly
greater than that of WKY in all groups of rats. The
phenylephrine-induced stress in intact females SHR was
reduced by 30% compared with that in intact male SHR.
|
We investigated whether the observed gender differences in active stress reflect changes in Ca2+ release from the intracellular stores. In Ca2+-free (2 mmol/L EGTA) Krebs' solution, phenylephrine (10-5 mol/L) and caffeine (25 mmol/L) caused a transient increase in active stress in the aorta of intact male WKY, which was not significantly different from that in WKY or SHR intact female, castrated male, OVX female, or OVX female rats with 17ß-estradiol implants (Table).
|
We tested whether the observed gender differences in active stress reflect changes in Ca2+ entry from the extracellular space. In unstimulated tissues, the basal Ca2+ influx was 13.1±1.2 µmol/kg per minute (n=20) in the aorta of intact male WKY, which was slightly but not significantly greater than or lower than that in intact female, castrated male, or OVX female WKY. Phenylephrine increased Ca2+ influx to 24.2±1.2 µmol/kg per minute (n=20) in intact male WKY (Figure 1B). The phenylephrine-induced increases in Ca2+ influx were significantly reduced by 20% in intact female WKY. The phenylephrine-induced Ca2+ influx was not significantly different between intact males and castrated males but was significantly greater in OVX females than in intact females. There was no significant difference in the phenylephrine-stimulated Ca2+ influx between OVX female and castrated male WKY. In OVX female WKY with 17ß-estradiol implants, the phenylephrine-induced Ca2+ influx was not significantly different from that in intact female WKY (Figure 1B). In SHR, the phenylephrine-induced Ca2+ influx was significantly greater than that of WKY in all groups of rats. The phenylephrine-induced Ca2+ influx in intact female SHR was reduced by 28% compared with that in intact male SHR.
To investigate the possible Ca2+ entry pathway
involved, we measured active stress and Ca2+
influx in the presence of 96 mmol/L KCl. Membrane depolarization
by 96 mmol/L KCl is known to stimulate Ca2+
entry through voltage-gated Ca2+
channels.9 17 KCl caused a contraction that reached a
plateau at
15 minutes, and therefore the KCl response was compared
at this time in all groups of rats. KCl increased active stress to
13.91±0.62x103 N/m2
(n=12) (Figure 2A) and
Ca2+ influx to 28.2±1.5 µmol/kg per
minute (n=20) (Figure 2B) in the aorta of intact male WKY. The
KCl-induced stress and Ca2+ influx were
significantly reduced by 19% and 21%, respectively, in intact female
WKY. The KCl-induced responses were not significantly different between
intact and castrated males but were significantly greater in OVX
females than in intact females. There was no significant difference in
KCl-induced stress or Ca2+ influx between OVX
female and castrated male WKY. In OVX female WKY with 17ß-estradiol
implants, the KCl-induced stress and Ca2+ influx
were not significantly different from those in intact female WKY
(Figure 2). In SHR, the KCl-induced active stress and
Ca2+ influx were significantly greater than those
of WKY in all groups of rats. The KCl-induced active stress and
Ca2+ influx in intact female SHR were reduced by
28% and 27%, respectively, compared with those in intact male
SHR.
|
Since the gender difference could involve a multitude of factors in vivo, we tested the direct effect of exogenous application of 17ß-estradiol on maximal phenylephrine- and KCl-induced contraction and Ca2+ influx. 17ß-Estradiol caused concentration-dependent relaxation of phenylephrine-induced contraction. As shown in Figure 3A, 17ß-estradiol was more potent in inhibiting the phenylephrine-induced stress in OVX female SHR (IC50=4.0±0.2x10-7 mol/L; n=12) than OVX female WKY (IC50=1.2±0.2x10-6 mol/L; n=12). In OVX female WKY, when contraction to EC50 of phenylephrine (3x10-7 mol/L) was elicited and then 17ß-estradiol was added, the IC50 for 17ß-estradiol was 1.1±0.2x10-6 mol/L; n=8), which was not significantly different from that when maximal contractions to phenylephrine (10-5 mol/L) were generated, and 17ß-estradiol was then added (IC50=1.2±0.2x10-6 mol/L; n=12). In addition, 17ß-estradiol (10-6 mol/L) caused greater inhibition of phenylephrine-induced Ca2+ entry in OVX female SHR (30%) than OVX female WKY (23%) (Figure 3C). Similarly, 17ß-estradiol was more potent in inhibiting the KCl-induced stress in OVX female SHR (IC50=3.8±0.3x10-7 mol/L; n=12) than OVX female WKY (IC50=1.0±0.1x10-6 mol/L; n=12) (Figure 3B). 17ß-Estradiol (10-6 mol/L) also caused greater inhibition of KCl-induced Ca2+ entry in OVX female SHR (34%) than in OVX female WKY (19%) (Figure 3D).
|
| Discussion |
|---|
|
|
|---|
The present study showed that the maximum aortic contraction to the
-adrenergic agonist phenylephrine was greater in intact
male than in intact female WKY. These results are consistent
with other studies that have shown a greater contraction to vasopressin
in the aorta of intact male than intact female rats.19 The
observation that the vascular contractility was not
significantly different in castrated males compared with intact males
but was significantly enhanced in OVX females compared with intact
females suggests that the gender differences are less likely related to
androgens and more likely related to estrogens. Since the expression of
sex hormone receptors in arterial smooth muscle may vary
depending on the gender and the status of the gonads,20
the observed gender differences in the vascular reactivity to estrogen
may well be related to the relative abundance of estrogen receptors.
This is supported by reports that estrogen receptors have been
identified in the rat aorta21 22 23 and that females have
higher levels of estrogen receptors in their arteries than
males.24 However, the gender differences may also be
related to differences in the signaling mechanisms downstream from
receptor activation. We investigated whether the gender differences in
vascular reactivity reflect differences in the mechanisms of
Ca2+ mobilization in smooth muscle.
Phenylephrine-induced contraction is triggered by an
initial inositol 1,4,5-trisphosphate
(IP3)induced Ca2+ release
from intracellular stores and maintained Ca2+
entry from the extracellular space.9 17 We found that the
transient phenylephrine contraction in
Ca2+-free medium was not significantly different
among the different groups of rats, suggesting that the
IP3-induced Ca2+ release
mechanism is not affected by gender. Furthermore, caffeine, which
stimulates the Ca2+-induced
Ca2+ release mechanism,9 18 caused a
transient contraction that was similar in magnitude in the different
groups of rats, suggesting that the observed gender differences in
vascular reactivity are not related to the
Ca2+-induced Ca2+ release
mechanism.
Membrane depolarization by high KCl is known to mainly stimulate Ca2+ entry from the extracellular space.9 17 The observation that the KCl-induced contraction was greater in intact males than in intact females suggested gender differences in Ca2+ entry mechanisms. In addition, the enhanced KCl-induced contraction in OVX females compared with that in intact females lends support to the contention that the gender differences are more likely related to endogenous estrogens. This is also supported by the observations that the phenylephrine- and KCl-induced increases in aortic Ca2+ entry were reduced in the presence and enhanced in the absence of female gonads. The causes of the gender differences in Ca2+ entry are not clear but may be related to the plasmalemmal density and/or the permeability of the Ca2+ entry pathways, among other factors. This is supported by reports that the expression of the L-type Ca2+ channels in cardiac muscle is substantially increased in estrogen receptordeficient mice.25
We found that the vascular reactivity and Ca2+ entry in OVX female WKY with estrogen implant were not significantly different from those in intact female WKY, providing further evidence that endogenous estrogens may be involved in the observed gender differences. However, the observed gender differences in the mechanisms of Ca2+ mobilization in vascular smooth muscle could be due to a multitude of effects of sex hormones in vivo. On the other hand, we found that exogenous application of estrogen to vascular strips of OVX females caused significant inhibition of vascular reactivity and Ca2+ entry. These results are consistent with the reduced vascular reactivity observed in aortic strips of intact female rats and are in agreement with reports that estrogen causes vascular relaxation in preconstricted rabbit and porcine coronary artery.7 8 10 However, on the basis of these results we do not wish to draw conclusions on whether estrogen inhibits Ca2+ entry by direct or indirect action on plasmalemmal Ca2+ channels. Other studies have shown that estrogen blocks Ca2+ channels in cultured A7r526 and rat aortic smooth muscle cells.27 Although the properties of Ca2+ channels may be different in cultured cells, our measurements of Ca2+ entry in aortic smooth muscle are consistent with these reports.
In the present study, aortic strips of SHR showed greater vascular reactivity and Ca2+ entry than those of WKY in all groups of rats. These results are consistent with other studies that have shown increased vascular tone in various blood vessels of SHR.13 14 15 16 The greater reduction in vascular reactivity and Ca2+ entry in intact female SHR and OVX female SHR with estrogen implants or in response to exogenous application of estrogen on isolated vascular strips of OVX female SHR compared with those in WKY could be due to differences in the number of estrogen receptors or in the number or permeability of the Ca2+ channels. This is supported by reports that the activity of the L-type Ca2+ channels is enhanced in vascular smooth muscle cells of SHR.28 29
The present study showed gender differences in the vascular reactivity and 45Ca2+ influx to maximal concentrations of phenylephrine and KCl. However, on the basis of these results, we do not wish to draw a general conclusion that similar gender differences also occur at all concentrations of phenylephrine and KCl. Comparison of the whole concentration-response curves to phenylephrine or KCl in rats of different gender should, therefore, represent an interesting area for future experiments. It is also important to note that exogenous estrogen caused vascular relaxation at concentrations severalfold higher than those observed in the plasma of intact females. Although both exogenous application of estrogen and the endogenous presence of estrogen were associated with reduction in vascular reactivity and Ca2+ entry, we do not wish to make a definite conclusion that the cellular mechanisms of estrogen-induced relaxation in vascular strips and the possible vasorelaxant effects of estrogen in vivo are identical. The effects of estrogen on target tissues have been classically thought of as arising from genomic actions mediated through interaction with cytoplasmic receptors and translocation of the hormone-receptor complex to the nucleus. Although a genomic action of estrogen on the expression of the Ca2+ channels might underlie the decreased responsiveness of aortic strips of intact females, it is less likely to account for the acute vasorelaxant effects of exogenous 17ß-estradiol. The acute nature of the vasorelaxant effects of exogenous estrogen may represent additional nongenomic effects of estrogen on the mechanisms of Ca2+ entry into vascular smooth muscle.
Finally, since the present study was performed on strips of thoracic aorta, we cannot make a definite conclusion on whether the observed gender differences in the Ca2+ entry mechanisms of arterial vasoconstriction also occur in resistance vessels, which should represent an important area for future investigation.
Thus, the vascular reactivity due to Ca2+ entry into vascular smooth muscle, but not Ca2+ release from intracellular stores, is reduced in the presence and enhanced in the absence of female gonads. The gender-specific changes in vascular reactivity and Ca2+ entry are possibly related to endogenous estrogen. The gender-specific changes in vascular reactivity and Ca2+ entry are enhanced in hypertension.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received May 8, 1999; first decision July 1, 1999; accepted July 14, 1999.
| References |
|---|
|
|
|---|
2. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996;10:615624.[Abstract]
3.
Gerhard M, Ganz P. How do we explain the clinical
benefits of estrogen? From bedside to bench. Circulation.. 1995;92:58.
4. Stampfer MJ, Colditz GA, Willett WC, Mason JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year followup from the Nurses's Health Study. N Engl J Med. 1991;325:756762.[Abstract]
5.
Gisclard V, Miller VM, Vanhoutte PM. Effect of 17
beta-estradiol on endothelium-dependent responses in
the rabbit. J Pharmacol Exp Ther. 1988;244:1922.
6. Herrington DM, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 1994;73:951952.[Medline] [Order article via Infotrieve]
7. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17ß-estradiol in vitro. Br J Pharmacol. 1991;104:10331037.[Medline] [Order article via Infotrieve]
8. Harder DR, Coulson PB. Estrogen receptors and effects on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol. 1979;100:375382.[Medline] [Order article via Infotrieve]
9. Khalil RA, van Breemen C. Mechanisms of calcium mobilization and homeostasis in vascular smooth muscle and their relevance to hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1995:523540.
10.
Crews JK, Khalil RA. Antagonistic effects
of 17ß-estradiol, progesterone and testosterone on
Ca2+ entry mechanisms of coronary
vasoconstriction. Arterioscler Thromb Vasc Biol. 1999;19:10341040.
11. Landers JP, Spelsberg TC. New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit Rev Eukaryot Gene Expr. 1992;2:1963.[Medline] [Order article via Infotrieve]
12. Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am J Med. 1983;74:863869.[Medline] [Order article via Infotrieve]
13. Mulvany MJ, Nyborg N. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br J Pharmacol. 1980;71:585596.[Medline] [Order article via Infotrieve]
14.
Hayashi K, Epstein M, Loutzenhiser R. Pressure-induced
vasoconstriction of renal microvessels in normotensive and hypertensive
rats: studies in the isolated perfused hydronephrotic kidney.
Circ Res. 1989;65:14751484.
15.
Gebremedhin D, Fenoy FJ, Harder DR, Roman RJ. Enhanced
vascular tone in the renal vasculature of spontaneously hypertensive
rats. Hypertension. 1990;16:648654.
16.
Falcone JC, Granger HJ, Meininger GA. Enhanced myogenic
activation in skeletal muscle arterioles from spontaneously
hypertensive rats. Am J Physiol. 1993;265:H1847H1855.
17.
Khalil RA, Van Breemen C. Sustained contraction of
vascular smooth muscle: calcium influx or C-kinase activation?
J Pharmacol Exp Ther. 1988;244:537542.
18.
Leijeten PA, van Breemen C. The effects of caffeine on
the noradrenaline-sensitive calcium store in rabbit aorta.
J Physiol. 1984;357:327339.
19.
Stallone JN, Crofton JT, Share L. Sexual dimorphism in
vasopressin-induced contraction of rat aorta. Am J
Physiol. 1991;260:H453H458.
20. Tamaya T, Wada K, Nakagawa M, Misao R, Itoh T, Imai A, Mori H. Sexual dimorphism of binding sites of testosterone and dihydrotestosterone in rabbit model. Comp Biochem Physiol. 1993;105A:745749.
21. Nakao J, Chang W, Murota S, Orimo H. Estradiol-binding sites in rat aortic smooth muscle cells in culture. Arteriosclerosis. 1981;38:7580.
22.
Lin AL, Shain SA. Estrogen mediated cytoplasmic and
nuclear distribution of rat cardiovascular estrogen
receptors. Arteriosclerosis. 1985;5:668677.
23. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye J. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology. 1995;136:15231529.[Abstract]
24.
Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos
S, Beale CM, McNeill JG, Poole-Wilson PA. 17ß-Estradiol
attenuates acetylcholine-induced coronary arterial
constriction in women but not men with coronary heart disease.
Circulation. 1995;92:2430.
25.
Johnson BD, Zheng W, Korach KS, Scheuer T, Catterall
WA, Rubanyi GM. Increased expression of the cardiac L-type calcium
channel in estrogen receptor-deficient mice. J Gen
Physiol. 1997;110:135140.
26.
Zhang F, Ram JL, Standley PR, Sowers JR.
17ß-Estradiol attenuates voltage-dependent
Ca2+ currents in A7r5 vascular smooth muscle cell
line. Am J Physiol. 1994;266:C975C980.
27. Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata, Kurachi Y. 17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle. Eur J Pharmacol. 1995;294:625635.[Medline] [Order article via Infotrieve]
28. Kubo T, Taguchi K, Ueda M. L-type calcium channels in vascular smooth muscle cells from spontaneously hypertensive rats: effects of calcium agonist and antagonist. Hypertens Res. 1998;21:3337.[Medline] [Order article via Infotrieve]
29. Martens JR, Gelband CH. Ion channels in vascular smooth muscle: alterations in essential hypertension. Proc Soc Exp Biol Med. 1998;218:192203.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
Y. Xia and R. A. Khalil Sex-related decrease in [Ca2+]i signaling and Ca2+-dependent contraction in inferior vena cava of female rat Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2010; 298(1): R15 - R24. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Stennett, X. Qiao, A. E. Falone, V. V. Koledova, and R. A. Khalil Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H745 - H755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Kunert, M. R. Dwinell, I. Drenjancevic Peric, and J. H. Lombard Sex-specific differences in chromosome-dependent regulation of vascular reactivity in female consomic rat strains from a SS x BN cross Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R516 - R527. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Bowles, K. K. Maddali, V. K. Ganjam, L. J. Rubin, D. L. Tharp, J. R. Turk, and C. L. Heaps Endogenous testosterone increases L-type Ca2+ channel expression in porcine coronary smooth muscle Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2091 - H2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Kanashiro and R. A. Khalil Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle Am J Physiol Cell Physiol, January 1, 2001; 280(1): C34 - C45. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |